Literature DB >> 17437289

Graft versus leukemia effect against juvenile myelomonocytic leukemia after unrelated cord blood transplantation.

Reo Tanoshima1, Hiroaki Goto, Masakatsu Yanagimachi, Ryosuke Kajiwara, Fumiko Kuroki, Shumpei Yokota.   

Abstract

A 13-month-old female underwent unrelated cord blood transplantation (CBT) for juvenile myelomonocytic leukemia (JMML). In spite of progression of the disease after a conditioning regimen with high-dose chemotherapy, a complete remission was induced in concordance with development of acute GVHD after reduction of the immunosupressant. She has been in complete remission for 1 year after transplantation. This case illustrates that CBT can provide a potent graft versus leukemia (GVL) effect against JMML. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 17437289     DOI： 10.1002/pbc.21200

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN： 1545-5009            Impact factor:   3.167


  5 in total

1.  HLA-identical umbilical cord blood transplantation from a sibling donor in juvenile myelomonocytic leukemia.

Authors:  Andrica C H de Vries; Robbert G M Bredius; Arjan C Lankester; Marc Bierings; Monika Trebo; Petr Sedlacek; Charlotte M Niemeyer; Marco Zecca; Franco Locatelli; Marry M van den Heuvel-Eibrink
Journal:  Haematologica       Date:  2008-12-23       Impact factor: 9.941

2.  Different outcomes of allogeneic hematopoietic stem cell transplant in a pair of twins affected by juvenile myelomonocytic leukemia.

Authors:  Simone Cesaro; Paola De Filippi; Annamaria Di Meglio; Anna Leszl; Svetlana Donska; Ada Zaccaron; Claudia Cagioni; Roberta Galavotti; Cesare Danesino; Fiorenza Aprili; Chiara Cugno; Geertruy te Kronnie; Marco Zecca; Silvia Bresolin
Journal:  Int J Hematol       Date:  2013-12-12       Impact factor: 2.490

Review 3.  RAS diseases in children.

Authors:  Charlotte M Niemeyer
Journal:  Haematologica       Date:  2014-11       Impact factor: 9.941

4.  Analysis of risk factors influencing outcomes after cord blood transplantation in children with juvenile myelomonocytic leukemia: a EUROCORD, EBMT, EWOG-MDS, CIBMTR study.

Authors:  Franco Locatelli; Alessandro Crotta; Annalisa Ruggeri; Mary Eapen; John E Wagner; Margaret L Macmillan; Marco Zecca; Joanne Kurtzberg; Carmem Bonfim; Ajay Vora; Cristina Díaz de Heredia; Lochie Teague; Jerry Stein; Tracey A O'Brien; Henrique Bittencourt; Adrienne Madureira; Brigitte Strahm; Christina Peters; Charlotte Niemeyer; Eliane Gluckman; Vanderson Rocha
Journal:  Blood       Date:  2013-08-07       Impact factor: 22.113

5.  Use of Rapamycin in a Patient With Juvenile Myelomonocytic Leukemia: A Case Report.

Authors:  Shivani Y Upadhyay; Satiro N De Oliveira; Theodore B Moore
Journal:  J Investig Med High Impact Case Rep       Date:  2017-09-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.